Integral Health Asset Management’s Alkermes ALKS Stock Holding History

Integral Health Asset Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.24M	Buy	+100,000	New	+$3.91M	0.21%	74
2025 Q3	–	Sell	-100,000	Closed	-$2.86M	–	78
2025 Q2	$2.86M	Sell	100,000 -50,000	-33%	-$1.49M	0.26%	67
2025 Q1	$4.95M	Buy	+150,000	New	+$4.89M	0.53%	52
2024 Q2	–	Sell	-250,000	Closed	-$6.77M	–	76
2024 Q1	$6.77M	Buy	250,000 +1,000	+0.4%	+$28.4K	0.63%	60
2023 Q4	$6.91M	Sell	249,000 -26,000	-9%	-$675K	0.94%	49
2023 Q3	$7.7M	Sell	275,000 -9,000	-3%	-$264K	1.07%	39
2023 Q2	$8.89M	Buy	284,000 +105,000	+59%	+$3.18M	1.1%	38
2023 Q1	$5.05M	Buy	+179,000	New	+$4.88M	1.02%	40
2022 Q4	–	Sell	-200,000	Closed	-$4.47M	–	63
2022 Q3	$4.47M	Sell	200,000 -61,966	-24%	-$1.61M	0.87%	45
2022 Q2	$7.8M	Buy	261,966 +11,966	+5%	+$344K	1.61%	21
2022 Q1	$6.58M	Buy	250,000 +200,000	+400%	+$4.95M	1.71%	22
2021 Q4	$1.16M	Buy	+50,000	New	+$1.31M	0.32%	63
2021 Q3	–	Sell	-150,000	Closed	-$3.68M	–	73
2021 Q2	$3.68M	Buy	+150,000	New	+$3.34M	1.01%	40
2020 Q2	–	Sell	-150,000	Closed	-$2.16M	–	62
2020 Q1	$2.16M	Buy	+150,000	New	+$2.68M	0.95%	38

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Integral Health Asset Management's ALKS Position: Q2 2026 in Review

Integral Health Asset Management opened a new position in Alkermes (ALKS) in Q2 2026: 100,000 shares worth $5.24M. The stake represents 0.21% of the portfolio and ranks #74 among its holdings. This is a return to the name: Integral Health Asset Management previously reported a position in ALKS as recently as Q2 2025.

Integral Health Asset Management first reported a position in ALKS in Q1 2020 and has held it in 14 quarters since. The position peaked at $8.89M in Q2 2023. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Integral Health Asset Management held 100,000 shares of Alkermes worth $5.24M as of Q2 2026.
Alkermes was a new Integral Health Asset Management position in Q2 2026.
Alkermes made up 0.21% of Integral Health Asset Management's portfolio in Q2 2026, its #74 holding.
Integral Health Asset Management first reported a position in Alkermes in Q1 2020 and has held it in 14 quarters since.
Integral Health Asset Management's Alkermes position peaked at $8.89M in Q2 2023.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.